Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(22 sites) United Kingdom
The Royal Hospitals Belfast, Belfast Birmingham and Midland Eye Centre, Birmingham Sussex Eye Hospital, Brighton Bristol Eye Hospital, Bristol Frimley Park Hospital, Camberley Gloucestershire Royal Hospital, Gloucester Hull Royal Infirmary, Hull Hinchingbrooke Hospital, Huntingdon Royal Liverpool University Hospital, Liverpool Central Middlesex Hospital, London Chelsea and Westminster Hospital, London Kings College Hospital, London Moorfields Eye Hospital, London James Cook Hospital, Middlesbrough Royal Gwent Hospital, Newport Queen's Medical Centre, Nottingham East Surrey Hospital, Redhill University Hospital Southampton, Southampton Sunderland Eye Hospital, Sunderland Singleton Hospital, Swansea Hillingdon Hospital, Uxbridge Key details Sponsor
Belfast Health and Social Care Trust
Collaborators
Queen's University, Belfast
Enrollment target
~264 participants
Primary completion
November 2028
Last updated September 2025